Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer
Benjamin R. Roman(Memorial Sloan Kettering Cancer Center), Judy A. Shea(University of Pennsylvania), Samuel Swisher‐McClure(University of Pennsylvania), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Alexander Lin(University of Pennsylvania Health System), David Goldenberg(Pennsylvania State University), David Myssiorek(New York University), Snehal G. Patel(Nirma University), Anna M. Pou(The University of Texas Medical Branch at Galveston), Marilene B. Wang(University of California, Los Angeles), F. Christopher Holsinger(Stanford University)
Cited by 37
Related Papers
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
|Cancer Cell|2006|584
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
|Movement Disorders|2009|535